A systematic review and meta-analysis on the antibiotic resistance of Neisseria meningitidis in the last 20 years in the world.

[1]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[2]  G. Ippolito,et al.  Antimicrobial resistance preparedness in sub-Saharan African countries , 2020, Antimicrobial resistance and infection control.

[3]  B. T. Tadesse,et al.  Antimicrobial sensitivity profile and bacterial isolates among suspected pyogenic meningitis patients attending at Hawassa University Hospital: Cross-sectional study , 2020, BMC Microbiology.

[4]  M. Ceyhan,et al.  Surveillance of penicillin resistance of Neisseria meningitidis strains from invasive infections between 2013 and 2018 in Turkey , 2020, Journal of chemotherapy.

[5]  M. Tiruneh,et al.  Carriage rate of Neisseria meningitidis, antibiotic susceptibility pattern and associated risk factors among primary school children in Gondar town, Northwest Ethiopia , 2019, BMC Infectious Diseases.

[6]  F. Mulatu,et al.  Antibiotic Susceptibility Patterns of Neisseria Meningitides Isolates from Asymptomatic Carriers in Gurage Zone, Southern Ethiopia , 2019, American Journal of Health Research.

[7]  P. De Wals,et al.  The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations , 2019, Expert review of vaccines.

[8]  A. Sahebkar,et al.  Antibiotic resistance of Neisseria species in Iran: A systematic review and meta-analysis , 2019, Asian Pacific Journal of Tropical Medicine.

[9]  N. Boudebouch,et al.  Emergence and spread of resistant N. meningitidis implicated in invasive meningococcal diseases during the past decade (2008–2017) , 2018, The Journal of Antibiotics.

[10]  P. Stefanelli,et al.  Neisseria meningitidis Antimicrobial Resistance in Italy, 2006 to 2016 , 2018, Antimicrobial Agents and Chemotherapy.

[11]  M. Gorla,et al.  Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016 , 2018, Journal of medical microbiology.

[12]  A. Akya,et al.  The Mutations of Topoisomerase Genes and Their Effect on Resistance to Fluoroquinolones in Extended-Spectrum β-Lactamase-Producing Escherichia coli , 2018 .

[13]  T. Alemayehu,et al.  Nasal carriage rate and antibiotic susceptibility pattern of Neisseria meningitidis in healthy Ethiopian children and adolescents: A cross-sectional study , 2017, PloS one.

[14]  E. Ashley,et al.  Antimicrobial resistance in Africa: a systematic review , 2017, BMC Infectious Diseases.

[15]  Mohammad M. Aboulwafa,et al.  Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations , 2017, PloS one.

[16]  F. Fallah,et al.  Acute bacterial meningitis in Iran: Systematic review and meta-analysis , 2017, PloS one.

[17]  A. Deghmane,et al.  Emergence of meningococci with reduced susceptibility to third-generation cephalosporins , 2017, The Journal of antimicrobial chemotherapy.

[18]  S. Nadel.  Treatment of Meningococcal Disease. , 2016, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[19]  P. Stefanoff,et al.  European public health policies for managing contacts of invasive meningococcal disease cases better harmonised in 2013 than in 2007. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  B. Harcourt,et al.  Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States , 2015, Open forum infectious diseases.

[21]  G. Bouba,et al.  Neisseria meningitidis susceptibility in North-Cameroon. , 2014, Medecine et maladies infectieuses.

[22]  M. Ahangarzadeh Rezaee,et al.  Etiology and Antimicrobial Resistance Patterns of Acute Bacterial Meningitis in Children: A 10-Year Referral Hospital-Based Study in Northwest Iran , 2014, Iranian Red Crescent medical journal.

[23]  W. Hryniewicz,et al.  A Decade of Invasive Meningococcal Disease Surveillance in Poland , 2013, PloS one.

[24]  Mucheye Gizachew,et al.  Bacterial profile and antimicrobial susceptibility pattern in septicemia suspected patients attending Gondar University Hospital, Northwest Ethiopia , 2013, BMC Research Notes.

[25]  A. Corso,et al.  Phenotypic and Genotypic Characteristics of Neisseria meningitidis Disease-Causing Strains in Argentina, 2010 , 2013, PloS one.

[26]  M. Unemo,et al.  Target Gene Sequencing To Define the Susceptibility of Neisseria meningitidis to Ciprofloxacin , 2013, Antimicrobial Agents and Chemotherapy.

[27]  H. Belabbes,et al.  Epidemiological profile of invasive bacterial diseases in children in Casablanca, Morocco: antimicrobial susceptibilities and serotype distribution. , 2012, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[28]  R. Wintjens,et al.  Evolutionary Changes in Antimicrobial Resistance of Invasive Neisseria meningitidis Isolates in Belgium from 2000 to 2010: Increasing Prevalence of Penicillin Nonsusceptibility , 2012, Antimicrobial Agents and Chemotherapy.

[29]  M. Gorla,et al.  Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008. , 2011, Enfermedades infecciosas y microbiologia clinica.

[30]  A. Gori,et al.  Imported Ciprofloxacin-Resistant Neisseria meningitidis , 2009, Emerging infectious diseases.

[31]  H. Ahmed,et al.  Changing pattern of antibiotic sensitivity of Neisseriae meningitidis from children with Meningococcal meningitis in North Eastern Nigeria. , 2009, Nigerian journal of clinical practice.

[32]  M. Unemo,et al.  Antibiotic Susceptibility and Characteristics of Neisseria meningitidis Isolates from the African Meningitis Belt, 2000 to 2006: Phenotypic and Genotypic Perspectives , 2009, Antimicrobial Agents and Chemotherapy.

[33]  M. Pană,et al.  The in vitro susceptibility to 7 antibiotics of Neisseria meningitidis strains isolated last years in Romania. , 2009, Roumanian archives of microbiology and immunology.

[34]  V. Temper,et al.  Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin , 2008, Emerging infectious diseases.

[35]  A. Norazah,et al.  Serogroups and antibiotic susceptibility patterns of Neisseria meningitidis isolated from army recruits in a training camp. , 2007, The Malaysian journal of pathology.

[36]  S. Gupta,et al.  Extensively Drug-resistant Tuberculosis, Italy and Germany , 1958, Emerging infectious diseases.

[37]  A. Kassu,et al.  Bacterial isolates from cerebrospinal fluids and their antibiotic susceptibility patterns in Gondar University Teaching Hospital, Northwest Ethiopia , 2005 .

[38]  J. Jorgensen,et al.  Susceptibility of Neisseria meningitidis to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some Agents , 2005, Journal of Clinical Microbiology.

[39]  Ronald N. Jones,et al.  Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis). , 2005, Diagnostic microbiology and infectious disease.

[40]  Allan R Tunkel,et al.  Practice guidelines for the management of bacterial meningitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  B. Nunes,et al.  Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001). , 2004, Journal of medical microbiology.

[42]  P. Ringwald,et al.  Antimicrobial resistance. , 2001, Emerging infectious diseases.

[43]  T. Popović,et al.  Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa. , 2001, Emerging infectious diseases.

[44]  M. Tanner,et al.  Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana , 2000, Tropical medicine & international health : TM & IH.

[45]  P. Courvalin,et al.  High-level chloramphenicol resistance in Neisseria meningitidis. , 1998, The New England journal of medicine.

[46]  B. Oppenheim.  Antibiotic resistance in Neisseria meningitidis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  A. Tunkel,et al.  Pathogenesis and pathophysiology of bacterial meningitis , 1993, Clinical Microbiology Reviews.

[48]  T. Riordan,et al.  Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7. , 1989, BMJ.